Benzinga | Aug 2, 2021 08:59AM EDT

Barclays Maintains Overweight on IDEXX Laboratories, Raises Price Target to $750

Barclays analyst Balaji Prasad maintains IDEXX Laboratories (NASDAQ:IDXX) with a Overweight and raises the price target from $616 to $750.